Atlas Trials

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Clinical trial NCT00997685 · UNKNOWN

Trial details

NCT number
NCT00997685
Sponsor
Guangdong Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Potentially Resectable Liver Metastasis From CRCColorectal Cancer
Start date
2009-11-01
Primary completion
2015-10-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.